Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson's Disease in the United States
- PMID: 23083512
- PMCID: PMC3562561
- DOI: 10.1016/j.parkreldis.2012.09.014
Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson's Disease in the United States
Abstract
Background: To determine the demographic distribution of Young Onset Parkinson's Disease (YOPD) in the United States and to quantify the burden of neuropsychiatric disease manifestations.
Methods: Cross sectional study of 3,459,986 disabled Americans, aged 30-54, who were receiving Medicare benefits in the year 2005. We calculated race and sex distributions of YOPD and used logistic regression to compare the likelihood of common and uncommon psychiatric disorders between beneficiaries with YOPD and the general disability beneficiary population, adjusting for race, age, and sex.
Results: We identified 14,354 Medicare beneficiaries with YOPD (prevalence = 414.9 per 100,000 disabled Americans). White men comprised the majority of cases (48.9%), followed by White women (34.7%), Black men (6.8%), Black women (5.0%), Hispanic men (2.4%), and Hispanic women (1.2%). Asian men (0.6%) and Asian women (0.4%) were the least common race-sex pairs with a YOPD diagnosis in this population (chi square, p < 0.001). Compared to the general population of medically disabled Americans, those with YOPD were more likely to receive medical care for depression (OR: 1.89, 1.83-1.95), dementia (OR: 7.73, 7.38-8.09), substance abuse/dependence (OR: 3.00, 2.99-3.01), and were more likely to be hospitalized for psychosis (OR: 3.36, 3.19-3.53), personality/impulse control disorders (OR: 4.56, 3.28-6.34), and psychosocial dysfunction (OR: 3.85, 2.89-5.14).
Conclusions: Young Onset Parkinson's Disease is most common among white males in our study population. Psychiatric illness, addiction, and cognitive impairment are more common in YOPD than in the general population of disabled Medicare beneficiaries. These may be key disabling factors in YOPD.
Copyright © 2012 Elsevier Ltd. All rights reserved.
References
-
- Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M. Young-versus older-onset Parkinson’s disease: impact of disease and psychosocial consequences. Mov Disord. 2003 Nov;18(11):1250–6. - PubMed
-
- Wickremaratchi MM, Knipe MD, Sastry BS, Morgan E, Jones A, Salmon R, et al. The motor phenotype of Parkinson’s disease in relation to age at onset. Mov Disord. 2011 Feb 15;26(3):457–63. - PubMed
-
- Schrag A, Ben-Shlomo Y, Brown R, Marsden CD, Quinn N. Young-onset Parkinson’s disease revisited--clinical features, natural history, and mortality. Mov Disord. 1998 Nov;13(6):885–94. - PubMed
-
- Calne SM, Kumar A. Young onset Parkinson’s disease. Practical management of medical issues. Parkinsonism Relat Disord. 2008;14(2):133–42. - PubMed
Publication types
MeSH terms
Grants and funding
- K23 NS081087/NS/NINDS NIH HHS/United States
- K24ES017765/ES/NIEHS NIH HHS/United States
- R01 CA112159/CA/NCI NIH HHS/United States
- R01 ES013743/ES/NIEHS NIH HHS/United States
- T32 NS007205/NS/NINDS NIH HHS/United States
- U10 NS044455/NS/NINDS NIH HHS/United States
- 5T32NS007205-27/NS/NINDS NIH HHS/United States
- KL2 RR024994/RR/NCRR NIH HHS/United States
- KL2 TR000450/TR/NCATS NIH HHS/United States
- R21 ES017504/ES/NIEHS NIH HHS/United States
- P42 ES004696/ES/NIEHS NIH HHS/United States
- K24 ES017765/ES/NIEHS NIH HHS/United States
- R01 CA137750/CA/NCI NIH HHS/United States
- UL1RR024992/RR/NCRR NIH HHS/United States
- UL1 RR024992/RR/NCRR NIH HHS/United States
- R01 NS037167/NS/NINDS NIH HHS/United States
- R01 CA109675/CA/NCI NIH HHS/United States
- UL1 TR000448/TR/NCATS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
